Home Privacy Archive Realtime Report

Stock Trading History of Bahcall Safi R

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bahcall Safi R since year 2005. The trader's CIK number is 1325719. At the time of this reporting, Bahcall Safi R is the President and CEO of Synta Pharmaceuticals Corp (stock ticker symbol SNTA).

Stock purchases, sales, and option exercises reported by *Bahcall Safi R* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2007-11-26	SNTA	Synta Pharmaceuticals Corp	Purchase	5,000	7.83	39,140

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bahcall Safi R (President and CEO of Synta Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.